Evaluation of serum parathyroid hormone-related peptide in hyperthyroid patients

Eur J Clin Invest 2010; 41 (1): 93–97 Background  Hypercalcemia occurs in 10–20% of patients with hyperthyroidism, but its pathogenesis is still unclear. Aim  To evaluate changes in parathyroid hormone‐related peptide (PTH‐rP) concentration in hyperthyroid patients compared with healthy controls. Me...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical investigation 2011-01, Vol.41 (1), p.93-97
Main Authors: Giovanella, Luca, Suriano, Sergio, Keller, Franco, Borretta, Giorgio, Ceriani, Luca
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Antithyroid Agents - therapeutic use
Biological and medical sciences
Carbimazole - therapeutic use
Case-Control Studies
Endocrinopathies
Female
General aspects
Graves' disease
Humans
hyperthyroidism
Hyperthyroidism - drug therapy
Hyperthyroidism - metabolism
ionized calcium
Male
Medical sciences
Middle Aged
Non tumoral diseases. Target tissue resistance. Benign neoplasms
parathormone
parathormone-related peptide
Parathyroid Hormone - metabolism
Parathyroid Hormone - therapeutic use
Parathyroid Hormone-Related Protein - metabolism
Thyroid. Thyroid axis (diseases)
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Eur J Clin Invest 2010; 41 (1): 93–97 Background  Hypercalcemia occurs in 10–20% of patients with hyperthyroidism, but its pathogenesis is still unclear. Aim  To evaluate changes in parathyroid hormone‐related peptide (PTH‐rP) concentration in hyperthyroid patients compared with healthy controls. Methods  We studied PTH‐rP, parathormone (PTH) and ionized calcium levels in 153 hyperthyroid patients, and 89 control subjects. These variables were revaluated after attainment of euthyroidism with the antithyroid drug carbimazole for 6 months in a subgroup of 47 patients. Results  Pretreatment PTH‐rP and ionized calcium level were significantly higher in hyperthyroid patients than in controls, whereas an opposite trend occurred for PTH. All parameters normalized after carbimazole therapy. Conclusion  Untreated hyperthyroid patients exhibited a significant elevation in serum ionized calcium and PTH‐rP and a significant reduction in serum PTH levels when compared with healthy controls. Our data favoured the hypothesis of a direct involvement of PTH‐rP in the pathogenesis of hypercalcemia in hyperthyroid patients.
ISSN:0014-2972
1365-2362
DOI:10.1111/j.1365-2362.2010.02385.x